Richard Newitter
Stock Analyst at Truist Securities
(4.18)
# 498
Out of 5,044 analysts
402
Total ratings
53.53%
Success rate
13.09%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Hold | $82 → $87 | $82.20 | +5.84% | 20 | Oct 28, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $121 → $88 | $68.28 | +28.88% | 10 | Oct 24, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $129 → $130 | $101.55 | +28.02% | 19 | Oct 23, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $525 → $620 | $545.61 | +13.63% | 31 | Oct 22, 2025 | |
| VCEL Vericel | Maintains: Buy | $46 → $41 | $36.11 | +13.54% | 4 | Oct 15, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Hold | $14 → $16 | $15.34 | +4.30% | 2 | Oct 15, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $8 → $7 | $6.82 | +2.64% | 16 | Oct 15, 2025 | |
| SYK Stryker | Maintains: Hold | $415 → $407 | $377.88 | +7.71% | 22 | Oct 15, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $64 → $50 | $36.19 | +38.16% | 15 | Oct 15, 2025 | |
| PEN Penumbra | Maintains: Buy | $310 → $300 | $240.49 | +24.75% | 6 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $96 → $103 | $93.85 | +9.75% | 17 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $205 | $185.86 | +10.30% | 17 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $125 → $90 | $76.83 | +17.14% | 27 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $15.67 | -4.28% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $94 | $68.89 | +36.45% | 2 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $126 → $120 | $74.60 | +60.86% | 6 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $23.93 | +17.01% | 3 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $13.19 | +36.47% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $111 → $63 | $57.34 | +9.87% | 19 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $365 | $324.89 | +12.35% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $80 → $68 | $62.97 | +7.99% | 27 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $131.50 | +4.18% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $16.93 | +41.76% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $101.55 | +11.28% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $15.59 | +34.70% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $8.71 | +129.62% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $75.17 | +9.09% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $184.95 | +35.17% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $4.25 | +512.49% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $133.93 | +474.93% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $73.98 | +14.90% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $11.89 | +68.21% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $17.44 | +54.82% | 5 | Feb 23, 2021 |
Edwards Lifesciences
Oct 28, 2025
Maintains: Hold
Price Target: $82 → $87
Current: $82.20
Upside: +5.84%
Integer Holdings
Oct 24, 2025
Maintains: Buy
Price Target: $121 → $88
Current: $68.28
Upside: +28.88%
Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $129 → $130
Current: $101.55
Upside: +28.02%
Intuitive Surgical
Oct 22, 2025
Maintains: Buy
Price Target: $525 → $620
Current: $545.61
Upside: +13.63%
Vericel
Oct 15, 2025
Maintains: Buy
Price Target: $46 → $41
Current: $36.11
Upside: +13.54%
Tandem Diabetes Care
Oct 15, 2025
Maintains: Hold
Price Target: $14 → $16
Current: $15.34
Upside: +4.30%
Treace Medical Concepts
Oct 15, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $6.82
Upside: +2.64%
Stryker
Oct 15, 2025
Maintains: Hold
Price Target: $415 → $407
Current: $377.88
Upside: +7.71%
PROCEPT BioRobotics
Oct 15, 2025
Maintains: Buy
Price Target: $64 → $50
Current: $36.19
Upside: +38.16%
Penumbra
Oct 15, 2025
Maintains: Buy
Price Target: $310 → $300
Current: $240.49
Upside: +24.75%
Oct 15, 2025
Maintains: Hold
Price Target: $96 → $103
Current: $93.85
Upside: +9.75%
Oct 15, 2025
Maintains: Buy
Price Target: $175 → $205
Current: $185.86
Upside: +10.30%
Oct 15, 2025
Maintains: Hold
Price Target: $125 → $90
Current: $76.83
Upside: +17.14%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $15.67
Upside: -4.28%
Oct 15, 2025
Maintains: Buy
Price Target: $102 → $94
Current: $68.89
Upside: +36.45%
Sep 22, 2025
Maintains: Buy
Price Target: $126 → $120
Current: $74.60
Upside: +60.86%
Sep 22, 2025
Maintains: Buy
Price Target: $21 → $28
Current: $23.93
Upside: +17.01%
Aug 18, 2025
Initiates: Buy
Price Target: $18
Current: $13.19
Upside: +36.47%
Aug 12, 2025
Downgrades: Hold
Price Target: $111 → $63
Current: $57.34
Upside: +9.87%
Jun 16, 2025
Initiates: Buy
Price Target: $365
Current: $324.89
Upside: +12.35%
May 12, 2025
Maintains: Hold
Price Target: $80 → $68
Current: $62.97
Upside: +7.99%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $131.50
Upside: +4.18%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $16.93
Upside: +41.76%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $101.55
Upside: +11.28%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $15.59
Upside: +34.70%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $8.71
Upside: +129.62%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $75.17
Upside: +9.09%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $184.95
Upside: +35.17%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $4.25
Upside: +512.49%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $133.93
Upside: +474.93%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $73.98
Upside: +14.90%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $11.89
Upside: +68.21%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $17.44
Upside: +54.82%